A_DT
nuclear_JJ
factor_NN
NF-GM2_NN
that_WDT
interacts_VBZ
with_IN
a_DT
regulatory_JJ
region_NN
of_IN
the_DT
GM-CSF_NN
gene_NN
essential_JJ
for_IN
its_PRP$
induction_NN
in_IN
responses_NNS
to_TO
T-cell_NN
activation_NN
:_:
purification_NN
from_IN
human_JJ
T-cell_NN
leukemia_NN
line_NN
Jurkat_NN
cells_NNS
and_CC
similarity_NN
to_TO
NF-kappa_NN
B_NN
._.

Activation_NN
of_IN
T_NN
cells_NNS
by_IN
antigen_NN
,_,
lectin_NN
,_,
or_CC
a_DT
combination_NN
of_IN
phorbol-12-myristate_NN
acetate_NN
-LRB-_-LRB-
PMA_NN
-RRB-_-RRB-
and_CC
calcium_NN
ionophore_NN
-LRB-_-LRB-
A23187_NN
-RRB-_-RRB-
leads_VBZ
to_TO
the_DT
induction_NN
of_IN
genes_NNS
for_IN
a_DT
set_NN
of_IN
lymphokines_NNS
,_,
including_VBG
granulocyte-macrophage_JJ
colony-stimulating_JJ
factor_NN
-LRB-_-LRB-
GM-CSF_NN
-RRB-_-RRB-
._.

We_PRP
demonstrated_VBD
in_IN
earlier_JJR
studies_NNS
that_IN
the_DT
upstream_JJ
region_NN
of_IN
the_DT
mouse_NN
GM-CSF_NN
promoter_NN
at_IN
positions_NNS
between_IN
-95_CD
and_CC
-73_CD
is_VBZ
essential_JJ
for_IN
transcriptional_JJ
activation_NN
in_IN
response_NN
to_TO
PMA\/A23187_NN
._.

This_DT
region_NN
contains_VBZ
two_CD
DNA-binding_JJ
motifs_NNS
,_,
GM2_NN
and_CC
GC-box_NN
._.

The_DT
GM2_NN
sequence_NN
-LRB-_-LRB-
GGTAGTTCCC_NN
-RRB-_-RRB-
is_VBZ
recognized_VBN
by_IN
an_DT
inducible_JJ
factor_NN
NF-GM2_NN
;_:
the_DT
other_JJ
-LRB-_-LRB-
CCGCCC_NN
-RRB-_-RRB-
by_IN
constitutive_JJ
factors_NNS
A1_NN
,_,
A2_NN
,_,
and_CC
B_NN
._.

To_TO
elucidate_VB
the_DT
mechanism_NN
of_IN
GM-CSF_NN
gene_NN
activation_NN
,_,
we_PRP
have_VBP
purified_VBN
the_DT
inducible_JJ
factor_NN
NF-GM2_NN
from_IN
the_DT
nuclear_JJ
extract_NN
of_IN
stimulated_VBN
Jurkat_NN
cells_NNS
on_IN
the_DT
basis_NN
of_IN
specific_JJ
DNA-binding_JJ
activity_NN
._.

The_DT
purified_VBN
NF-GM2_NN
consists_VBZ
of_IN
50_CD
-LRB-_-LRB-
p50_NN
-RRB-_-RRB-
and_CC
65_CD
kDa_NN
-LRB-_-LRB-
p65_NN
-RRB-_-RRB-
polypeptides_NNS
and_CC
has_VBZ
a_DT
binding_NN
activity_NN
specific_JJ
for_IN
both_CC
the_DT
GM-CSF_NN
and_CC
immunoglobulin_NN
kappa_NN
-LRB-_-LRB-
GGAAAGTCCC_NN
-RRB-_-RRB-
enhancers_NNS
._.

Electrophoretically_RB
purified_VBN
p50_NN
alone_RB
can_MD
form_VB
a_DT
protein-DNA_JJ
complex_NN
,_,
but_CC
in_IN
the_DT
mixture_NN
,_,
p50_NN
associates_VBZ
preferentially_RB
with_IN
p65_NN
to_TO
form_VB
the_DT
NF-GM2_NN
complex_NN
._.

In_IN
addition_NN
,_,
p65_NN
gave_VBD
per_FW
se_FW
,_,
with_IN
low_JJ
affinity_NN
,_,
a_DT
protein-DNA_JJ
complex_NN
that_WDT
migrated_VBD
more_RBR
slowly_RB
than_IN
native_JJ
NF-GM2_NN
complex_NN
._.

Furthermore_RB
,_,
an_DT
antiserum_NN
against_IN
KBF1_NN
-LRB-_-LRB-
identical_JJ
to_TO
50_CD
kDa_NN
NF-kappa_NN
B_NN
protein_NN
-RRB-_-RRB-
reacted_VBD
with_IN
the_DT
p50_NN
of_IN
NF-GM2_NN
,_,
indicating_VBG
that_IN
the_DT
NF-GM2_NN
polypeptide_NN
can_MD
not_RB
be_VB
immunologically_RB
differentiated_VBN
from_IN
the_DT
50_CD
kDa_NN
subunit_NN
of_IN
NF-kappa_NN
B_NN
._.

The_DT
purified_VBN
NF-GM2_NN
activated_VBD
in_FW
vitro_FW
transcription_NN
from_IN
the_DT
kappa_NN
B_NN
enhancer_NN
,_,
while_IN
it_PRP
failed_VBD
to_TO
stimulate_VB
transcription_NN
from_IN
the_DT
GM-CSF_NN
promoter_NN
harboring_VBG
the_DT
GM2_NN
sequence_NN
._.

This_DT
suggests_VBZ
that_IN
the_DT
activation_NN
mechanism_NN
of_IN
the_DT
GM-CSF_NN
gene_NN
through_IN
the_DT
GM2\/GC-box_JJ
sequence_NN
is_VBZ
different_JJ
from_IN
that_DT
of_IN
genes_NNS
carrying_VBG
the_DT
kappa_NN
B_NN
enhancer_NN
alone_RB
._.

